GLP-1 medications such as semaglutide and tirzepatide have skyrocketed in popularity in a relatively short time and are reshaping the treatment of obesity and metabolic disease. As with most new phenomena, there are some gray areas that have yet to be fully explored. Microdosing GLP-1s has quietly entered the medical conversation at a time when many patients want to use it for weight loss and to maintain the benefits they’ve achieved.
Why GLP-1 Medications Are Reshaping Weight Loss
These medications were originally developed for patients with type 2 diabetes, but their effects on appetite regulation, insulin sensitivity and inflammation quickly pushed them into the spotlight for weight loss. Microdosing refers to using doses lower than the FDA-approved starting amounts to achieve specific goals such as appetite control, metabolic stability or maintenance. Financially, many have used microdosing as a way to “stretch” the medication and still achieve results.
Microdosing as an Entry Point or Exit Strategy
Chris Michaelis, DO, owner of Luminus Aesthetics, said microdosing often serves as an entry point or an exit strategy, depending on the patient. “We like to start people low anyway to see how they respond,” he explained. “You’re increasing insulin sensitivity while slowing gastric emptying, which helps people understand portion control and put lifestyle changes in place.” Microdosing can help patients hoping to lose 10 to 20 pounds get over the initial hurdle; then they can gradually taper off once they establish healthy habits.
In other cases, higher doses are more appropriate. Patients who are borderline diabetic, have significant excess fat or carry increased cardiovascular risk may need standard-dose GLP-1 therapy. “Those are usually lifelong treatments,” Dr. Michaelis said. “Microdosing isn’t meant to replace that. It’s a different tool for a different situation.”
Medical Supervision and Dose Adjustments
At its core, microdosing is not a do-it-yourself concept. Dr. Michaelis typically starts patients at doses well below labeled recommendations, with weekly injections and frequent follow-ups. Doses are adjusted every couple of weeks based on response, goals and side effects. “We don’t have patients adjust anything on their own,” he stressed. “If there’s nausea or fatigue, they call us and we evaluate them in the office.”
Side Effects and Why Lower Doses Appeal
Side-effect mitigation is one reason the concept of microdosing has gained traction. At lower doses, patients often experience fewer gastrointestinal symptoms such as nausea or vomiting, which can occur when GLP-1s are escalated too quickly. The slower pace allows the body to adapt while still benefiting from appetite suppression and improved blood sugar regulation.
Metabolic Benefits Beyond Weight Loss
Those metabolic effects are not limited to weight loss. Edmund Rhett, MD, of Rhett Women’s Center pointed out that many benefits of GLP-1 medications stem from reduced insulin levels overall.
“When you decrease the intake of starchy carbohydrates and ultra-processed foods, insulin levels drop,” he said. “High insulin tells your body to store everything as fat and prevents access to stored energy. These drugs help reverse that process, and inflammation often improves as well.”…